Navigation Links
DART Therapeutics Initiates Study of HT-100 For Duchenne Muscular Dystrophy
Date:7/15/2013

CAMBRIDGE, Mass., July 15, 2013 /PRNewswire/ --DART Therapeutics Inc., an innovative, new-model biotechnology firm focused on developing therapies for Duchenne muscular dystrophy (DMD), has initiated a phase 1b/2a study of its lead drug candidate, HT-100 (delayed-release halofuginone). The phase 1b study (with a six-month 2a extension) in patients will determine the safety and tolerability of different, increasing doses of HT-100, and explore trends in a range of efficacy endpoints.    

HT-100 is an orally available, small molecule drug candidate intended to reduce fibrosis and inflammation and promote healthy muscle fiber regeneration in boys with DMD. The phase 1b/2a clinical program will enroll 30 boys and young men with DMD, both ambulatory and non-ambulatory. Participating centers include University of California, Davis Medical Center (Sacramento, Calif.), Kennedy Krieger Institute, Johns Hopkins School of Medicine (Baltimore, MD), Washington University School of Medicine (St. Louis, MO), Cincinnati Children's Hospital Medical Center (Cincinnati, Ohio) and Nationwide Children's Hospital (Columbus, Ohio). DART expects to complete the study in mid 2014.

"Treating DMD requires a cocktail of therapies that will change over time," said Gene Williams, CEO of DART Therapeutics. "We believe HT-100 could be a valuable part of this cocktail—even a mini-cocktail on its own—because it demonstrates potential to address many different aspects of the disease in parallel, which could make it an exceptionally important therapy for all boys living with DMD."

DART's study will include boys aged six through 20, an atypical age range that allows investigators to evaluate HT-100's safety in a broad population as well as study its effect in different d
'/>"/>

SOURCE DART Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CLAAD Lauds Signature Therapeutics R&D Efforts To Reduce Prescription Drug Abuse
2. Global Antiviral Therapeutics Report - Technologies, Markets and Companies - 2013-2022
3. Sorrento Therapeutics and Ben-Gurion University Sign an Agreement for the Development of Anti-Hepatitis C Virus Antibodies
4. Shield Therapeutics Completes Recruitment to Pivotal Phase 3 Programme for Treatment of Iron Deficiency
5. Elcelyx Therapeutics Reports Positive Data for NewMet in Type 2 Diabetes at 2013 American Diabetes Association Scientific Sessions
6. Nile Therapeutics Announces Filing of Annual and Quarterly Reports to Become Current on SEC Filings
7. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
8. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
9. Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter
10. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
11. Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  Decision Resources ... surveyed infectious disease (ID) specialists are willing to ... Orbactiv (oritavancin) for use as OPAT, approximately two-thirds ... these agents to their hospital inpatients. However, our ... OPAT patients are initiated on OPAT following hospital ...
(Date:1/15/2014)... , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: ... ended November 30, 2013, compared to sales of $2,202,000 for ... Once again, this quarter has also shown growth over the ... first quarter of this fiscal year. Markets that experienced sales ...
(Date:1/15/2014)... GRAND RAPIDS, Mich. , Jan. 15, 2014 As ... of the flu virus, select Meijer pharmacies in ... and strep throat to eligible patients, enabling Meijer pharmacists to ... under strict protocol set by a physician participating in the ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... ATLANTA, Oct. 13, 2011 Anesthesiologists are quickly turning ... cost-effective, high quality care.  An annual survey of anesthesia ... of survey respondents indicating that IT solutions are a ... key driver in IT decisions.  The survey of 212 ...
... 13, 2011 Cumberland Pharmaceuticals Inc. ... release third quarter 2011 financial results after the market closes ... Internet webcast will be held on Thursday, November 3, 2011, ... To participate in the call, please dial 877-303-1298 (for ...
Cached Medicine Technology:Annual Survey Demonstrates Increased Demand for Anesthesia Information Management Systems 2Annual Survey Demonstrates Increased Demand for Anesthesia Information Management Systems 3
(Date:7/12/2014)... Salt Lake City, Utah (PRWEB) July 12, 2014 ... Five spotlighted two types of startups, with awards being ... UVEF’s new emphasis spotlighted Utah’s outstanding entrepreneur community with ... are proving a sustainable model with incoming revenue. , ... companies from across the state that are under 5 ...
(Date:7/12/2014)... A recent article released by Seattle's well known plastic ... those seeking cosmetic surgical procedures in summer months . ... heat begins to enliven the rainy Pacific Northwest, many people ... they didn’t work out as much during the winter as ... surge of people eager to look their best for their ...
(Date:7/12/2014)... Wright & Schulte LLC, an experienced law firm who is ... (case #59776/2014), announces they have launched a new TV advertising ... hair dye, Just For Men, has caused some men to ... areas. In addition to detailing symptoms that are allegedly ... being run by Wright & Schulte LLC will also provide ...
(Date:7/12/2014)... 2014 Floor-grade instrument ... out of 5. This above-average score represents favorable ... buyer negotiation power over the three years to ... “during the period, surging demand for healthcare services ... new product development, have placed upward pressure on ...
(Date:7/12/2014)... Augusta, GA (PRWEB) July 12, 2014 ... Nova Medical Centers, is pleased to announce that it ... , This new facility will join four Atlanta-based ... will be located at 3209 Deans Bridge Road, and ... Monday through Friday. , “With Nova’s treatment philosophy ...
Breaking Medicine News(10 mins):Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Best Summer Cosmetic Surgeries Revealed in Article By Seattle Plastic Surgeon 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2
... , SOUTHBOROUGH, Mass., Aug. 26 From summer camps to summer ... say the new flu strain is expected to be back in force this ... H1N1 flu, the C D C reported ... highest level. What does this mean for families? It,s important to ...
... , , KANSAS CITY, Mo., Aug. 26 ... n cer Ce n ter ... which supports the nation,s foremost cancer treatment and research network, has treated its first patient ... its new KCCC-Shawnee Mission office. , , KCCC is the only ...
... BPG ... sale of a 5.529 acre pad site to OrthopaediCare, formerly the Orthopedic Specialty Center (OSC) ... Philadelphia, ... nation’s leading private equity fund managers, has announced the sale of a 5.529 acre pad ...
... Building on the success of their send-a-gene feature on ... application built on the NewsCloud Social Media Toolkit. , ... a one stop source for genomics and other related ... few mouse clicks users can post stories from around ...
... , WASHINGTON, Aug. 26 Citing persistent ... (VA) will not exercise the third year of a five-year, ... Center (UTSWMC) to perform research into Gulf War Veterans, Illnesses ... suffered by Gulf War Veterans remains a priority for VA," ...
... Metastasis Dr. Amanda Harvey and colleagues at Brunel ... in breast cancer progression and dissemination. Their report can ... American Journal of Pathology . Breast cancer ... patients. Non-metastatic breast cancer cells rely on interactions with ...
Cached Medicine News:Health News:Monitoring for Fever Can Help With Early Detection of H1N1 - 'Swine Flu' 2Health News:New Precision Radiation Treatment System Fights Cancer 2Health News:New Precision Radiation Treatment System Fights Cancer 3Health News:BPG Properties, LTD. Announces Land Sale to OrthopaediCare, Formerly Orthopedic Specialty Center, in New Britain Corporate Center in Chalfont, Pennsylvania 2Health News:BPG Properties, LTD. Announces Land Sale to OrthopaediCare, Formerly Orthopedic Specialty Center, in New Britain Corporate Center in Chalfont, Pennsylvania 3Health News:The Omics Generation on Facebook 2Health News:VA Continues Gulf War Research, Cancels Contract with UTSW Medical Center 2Health News:Tips from the American Journal of Pathology 2Health News:Tips from the American Journal of Pathology 3Health News:Tips from the American Journal of Pathology 4Health News:Tips from the American Journal of Pathology 5
EC+ Extra Care Bariatric Bed...
... system is a unique healthcare ... dual width capability with a ... design. Specifically developed to accommodate ... the easy-to-use Tri-Flex I system ...
... Nebulizer W/ 7` CR Resistant Oxygen Tubing., ... treatment times , ,Provide fine particles ... respirable particles) than conventional nebulizers, ,Our ... deliver fast and effective treatment more efficiently ...
... Nebulizer Disposable Prefilled 28%-100% FIO 2 1000ML ... ,Our prefilled nebulizers provide unmatched performance and ... cool high-output aerosols adjustable from 28% to 100% ... of solutions: sterile water for inhalation, USP; 0.45% ...
Medicine Products: